3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Metastatic Adenocarcinoma of the Pancreas
1
Fallopian Tube Neoplasms
1
Carcinoma
1
Interventions
Pemetrexed
3
Carboplatin
3
durvalumab
2
Cisplatin
2
tremelimumab
1
repotrectinib
1
pralsetinib
1
osimertinib
1
brigatinib
1
atezolizumab
1
Surgical Procedures, Operative
1
Paclitaxel
1
Mitomycin
1
Gemcitabine
1
Crizotinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT02367781
2021-08-09
IMpower130
Hoffmann-La Roche
Phase 3
Completed
723 enrolled
28 charts
1 FDA